We are live on ! Find out more
BSA

Braun Stacey Associates Portfolio holdings

AUM $3.53B
1-Year Est. Return 63.32%
This Fund
S&P 500
This Quarter Est. Return
+18.84%
1 Year Est. Return
+63.32%
3 Year Est. Return
+230.74%
5 Year Est. Return
+346.7%
10 Year Est. Return
+1,599.29%
AUM
$2.76B
AUM Growth
+$318M
Cap. Flow
+$3.28M
Cap. Flow %
0.12%
Top 10 Hldgs %
33.65%
Holding
126
New
10
Increased
35
Reduced
63
Closed
14

Top Buys

Rank Stock Value
1
CME icon
CME Group
CME
+$24.5M
2
NFLX icon
Netflix
NFLX
+$23.9M
3
DGX icon
Quest Diagnostics
DGX
+$23.6M
4
QXO
QXO Inc
QXO
+$20.4M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$19.5M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$21.7M
2
MRVL icon
Marvell Technology
MRVL
+$15.5M
3
UNH icon
UnitedHealth
UNH
+$14.4M
4
TTD icon
Trade Desk
TTD
+$14M
5
HWM icon
Howmet Aerospace
HWM
+$13.4M

Sector Composition

Rank Sector Weight
1 Technology 29.99%
2 Financials 14.25%
3 Communication Services 11.45%
4 Industrials 9.49%
5 Healthcare 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITRI icon
26
Itron
ITRI
$4.49B
$28.6M 1.03%
217,104
-458
-0.2% -$51.8K
NFLX icon
27
Netflix
NFLX
$308B
$28.3M 1.02%
+211,430
New +$23.9M
EVR icon
28
Evercore
EVR
$11.9B
$28.2M 1.02%
104,423
-23,664
-18% -$5.2M
OLLI icon
29
Ollie's Bargain Outlet
OLLI
$4.83B
$28.1M 1.02%
213,402
+105,572
+98% +$12.1M
GOOG icon
30
Alphabet (Google) Class C
GOOG
$4.34T
$27.9M 1.01%
157,278
-40,885
-21% -$6.76M
BSX icon
31
Boston Scientific
BSX
$71.7B
$27.4M 0.99%
255,550
-9,238
-3% -$935K
FWONK icon
32
Liberty Media Series C
FWONK
$25.8B
$27.4M 0.99%
262,554
-43,425
-14% -$4.03M
PANW icon
33
Palo Alto Networks
PANW
$296B
$27.3M 0.99%
133,168
-11,394
-8% -$2.12M
RTX icon
34
RTX Corp
RTX
$299B
$27.1M 0.98%
185,676
+9,398
+5% +$1.25M
QXO
35
QXO Inc
QXO
$17.2B
$26.7M 0.97%
+1,241,230
New +$20.4M
ETR icon
36
Entergy
ETR
$50.5B
$26.5M 0.96%
318,754
-1,602
-0.5% -$132K
MCK icon
37
McKesson
MCK
$103B
$26.2M 0.95%
35,708
-254
-0.7% -$179K
MU icon
38
Micron Technology
MU
$991B
$25.8M 0.93%
209,345
-23,058
-10% -$2.15M
TXRH icon
39
Texas Roadhouse
TXRH
$13.7B
$25.7M 0.93%
137,396
-12,779
-9% -$2.29M
EHC icon
40
Encompass Health
EHC
$12.4B
$25.1M 0.91%
204,706
+81,501
+66% +$9.31M
BLK icon
41
Blackrock
BLK
$175B
$25M 0.91%
23,868
-376
-2% -$356K
LRCX icon
42
Lam Research
LRCX
$388B
$24.8M 0.9%
254,993
-44,555
-15% -$3.53M
CME icon
43
CME Group
CME
$95.5B
$24.8M 0.9%
+89,918
New +$24.5M
MMM icon
44
3M
MMM
$94.3B
$24.7M 0.89%
162,352
+2,996
+2% +$428K
DGX icon
45
Quest Diagnostics
DGX
$26.3B
$24.4M 0.88%
+135,952
New +$23.6M
GEV icon
46
GE Vernova
GEV
$266B
$24.2M 0.88%
45,807
+9,686
+27% +$4.03M
CELH icon
47
Celsius Holdings
CELH
$6.69B
$24M 0.87%
517,874
+352,129
+212% +$13.6M
LTH icon
48
Life Time Group Holdings
LTH
$9.78B
$23.5M 0.85%
775,397
+14,810
+2% +$439K
WEC icon
49
WEC Energy
WEC
$35.3B
$23.3M 0.84%
223,285
+1,643
+0.7% +$175K
BAC icon
50
Bank of America
BAC
$440B
$22.6M 0.82%
478,028
-200,535
-30% -$8.44M
1
2
3 4 5

Similar funds

TYCC
Texas Yale Capital Corp St. Petersburg, Florida $3.52B AUM 52.63% 1-Year Est. Return
TH
TCTC Holdings Dallas, Texas $3.51B AUM 30.71% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return
BCP
BDT Capital Partners Chicago, Illinois $3.51B AUM 31.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
DILIC
Dai-ichi Life Insurance Company Tokyo, Japan $3.49B AUM 27.28% 1-Year Est. Return
KCM
Kedalion Capital Management London, United Kingdom $3.48B AUM 17.74% 1-Year Est. Return
ACM
Aquatic Capital Management Chicago, Illinois $3.48B AUM 24.9% 1-Year Est. Return

Braun Stacey Associates's Q2 2025 Portfolio in Review

As of Q2 2025, Braun Stacey Associates held 126 positions worth $2.76B, up 13% from $2.45B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Braun Stacey Associates's Q2 2025 filing shows 10 new, 35 increased, 63 reduced and 14 closed positions. Its largest new stake was CME Group: 89,918 shares worth $24.8M. The largest sale was Vertex Pharmaceuticals, an estimated $21.7M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 26% a quarter earlier, followed by Financials and Communication Services.

  • Braun Stacey Associates's largest Q2 2025 buy was CME Group: 89,918 shares worth $24.8M.
  • Braun Stacey Associates added most to Celsius Holdings in Q2 2025, an estimated $13.6M increase.
  • Braun Stacey Associates's biggest Q2 2025 reduction was UnitedHealth, cutting an estimated $14.4M.
  • Braun Stacey Associates fully exited Vertex Pharmaceuticals in Q2 2025, selling an estimated $21.7M.
  • Braun Stacey Associates's ten largest holdings make up 34% of its $2.76B portfolio in Q2 2025.
  • Braun Stacey Associates opened 10 new positions and closed 14 in Q2 2025.
  • Braun Stacey Associates's portfolio value rose 13% quarter-over-quarter to $2.76B.

Based on Braun Stacey Associates's 13F filing for Q2 2025, filed 12 Aug 2025.